Literature DB >> 10888665

Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways.

M Fornaro1, C A Steger, A M Bennett, J J Wu, L R Languino.   

Abstract

The integrin cytoplasmic domain modulates cell proliferation, adhesion, migration, and intracellular signaling. The beta(1) integrin subunits, beta(1C) and beta(1A), that contain variant cytoplasmic domains differentially affect cell proliferation; beta(1C) inhibits proliferation, whereas beta(1A) promotes it. We investigated the ability of beta(1C) and beta(1A) to modulate integrin-mediated signaling events that affect cell proliferation and survival in Chinese hamster ovary stable cell lines expressing either human beta(1C) or human beta(1A). The different cytodomains of either beta(1C) or beta(1A) did not affect either association with the endogenous alpha(2), alpha(V), and alpha(5) subunits or cell adhesion to fibronectin or TS2/16, a mAb to human beta(1). Upon engagement of endogenous and exogenous integrins by fibronectin, cells expressing beta(1C) showed significantly inhibited extracellular signal-regulated kinase (ERK) 2 activation compared with beta(1A) stable cell lines. In contrast, focal adhesion kinase phosphorylation and Protein Kinase B/AKT activity were not affected. Selective engagement of the exogenously expressed beta(1C) by TS2/16 led to stimulation of Protein Kinase B/AKT phosphorylation but not of ERK2 activation; in contrast, beta(1A) engagement induced activation of both proteins. We show that Ras activation was strongly reduced in beta(1C) stable cell lines in response to fibronectin adhesion and that expression of constitutively active Ras, Ras 61 (L), rescued beta(1C)-mediated down-regulation of ERK2 activation. Inhibition of cell proliferation in beta(1C) stable cell lines was attributable to an inhibitory effect of beta(1C) on the Ras/MAP kinase pathway because expression of activated MAPK kinase rescued beta(1C) antiproliferative effect. These findings show that the beta(1C) variant, by means of a unique signaling mechanism, selectively inhibits the MAP kinase pathway by preventing Ras activation without affecting either survival signals stimulated by integrins or cellular interactions with the extracellular matrix. These findings highlight a role for beta(1)-specific cytodomain sequences in maintaining an intracellular balance of proliferation and survival signals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10888665      PMCID: PMC14916          DOI: 10.1091/mbc.11.7.2235

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  79 in total

1.  Mutational analysis of cell cycle inhibition by integrin beta1C.

Authors:  J E Meredith; W B Kiosses; Y Takada; M A Schwartz
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

2.  The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation.

Authors:  F Mainiero; C Murgia; K K Wary; A M Curatola; A Pepe; M Blumemberg; J K Westwick; C J Der; F G Giancotti
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

Review 3.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

4.  Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase.

Authors:  H C Chen; J L Guan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

5.  Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation.

Authors:  W G King; M D Mattaliano; T O Chan; P N Tsichlis; J S Brugge
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

6.  Mapping in vivo associations of cytoplasmic proteins with integrin beta 1 cytoplasmic domain mutants.

Authors:  J M Lewis; M A Schwartz
Journal:  Mol Biol Cell       Date:  1995-02       Impact factor: 4.138

7.  The novel structural motif Gln795-Gln802 in the integrin beta 1C cytoplasmic domain regulates cell proliferation.

Authors:  M Fornaro; D Q Zheng; L R Languino
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

8.  A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth.

Authors:  K K Wary; A Mariotti; C Zurzolo; F G Giancotti
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

9.  p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma.

Authors:  M Fornaro; G Tallini; D Q Zheng; W M Flanagan; M Manzotti; L R Languino
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

10.  Dissociation of FAK/p130(CAS)/c-Src complex during mitosis: role of mitosis-specific serine phosphorylation of FAK.

Authors:  Y Yamakita; G Totsukawa; S Yamashiro; D Fry; X Zhang; S K Hanks; F Matsumura
Journal:  J Cell Biol       Date:  1999-01-25       Impact factor: 10.539

View more
  13 in total

1.  Beta1 integrins mediate cell proliferation in three-dimensional cultures by regulating expression of the sonic hedgehog effector protein, GLI1.

Authors:  Hira Lal Goel; Jean M Underwood; Jeffrey A Nickerson; Chung-Cheng Hsieh; Lucia R Languino
Journal:  J Cell Physiol       Date:  2010-07       Impact factor: 6.384

2.  A novel intracellular fibulin-1D variant binds to the cytoplasmic domain of integrin beta 1 subunit.

Authors:  Waleed O Twal; Samar M Hammad; Sharon L Guffy; William S Argraves
Journal:  Matrix Biol       Date:  2015-02-03       Impact factor: 11.583

3.  Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation.

Authors:  Paul Fiorilli; Darren Partridge; Izabela Staniszewska; Jin Y Wang; Maja Grabacka; Kelvin So; Cezary Marcinkiewicz; Krzysztof Reiss; Kamel Khalili; Sidney E Croul
Journal:  Lab Invest       Date:  2008-09-15       Impact factor: 5.662

4.  Disruption of C-terminal cytoplasmic domain of betaPS integrin subunit has dominant negative properties in developing Drosophila.

Authors:  Alison L Jannuzi; Thomas A Bunch; Marc C Brabant; Steven W Miller; Leona Mukai; Michael Zavortink; Danny L Brower
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

5.  Regulation of mRNA and protein levels of beta1 integrin variants in human prostate carcinoma.

Authors:  E Perlino; M Lovecchio; R A Vacca; M Fornaro; L Moro; P Ditonno; M Battaglia; F P Selvaggi; M G Mastropasqua; P Bufo; L R Languino
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

6.  Analysis of conserved residues in the betapat-3 cytoplasmic tail reveals important functions of integrin in multiple tissues.

Authors:  Xiaojian Xu; Jeong H Ahn; Phebe Tam; Eun Jeong Yu; Sushil Batra; Erin J Cram; Myeongwoo Lee
Journal:  Dev Dyn       Date:  2010-03       Impact factor: 3.780

7.  Nuclear localization of the ERK MAP kinase mediated by Drosophila alphaPS2betaPS integrin and importin-7.

Authors:  Brian P James; Thomas A Bunch; Srinivasan Krishnamoorthy; Lizabeth A Perkins; Danny L Brower
Journal:  Mol Biol Cell       Date:  2007-08-15       Impact factor: 4.138

8.  Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells.

Authors:  Min Fei; Qinglei Hang; Sicong Hou; Changgeng Ruan
Journal:  Int J Hematol       Date:  2013-09-14       Impact factor: 2.490

9.  CD29 is highly expressed on epithelial, myoepithelial, and mesenchymal stromal cells of human salivary glands.

Authors:  P P Togarrati; N Dinglasan; S Desai; W R Ryan; M O Muench
Journal:  Oral Dis       Date:  2018-03-13       Impact factor: 3.511

10.  Beta1 integrin cytoplasmic variants differentially regulate expression of the antiangiogenic extracellular matrix protein thrombospondin 1.

Authors:  Hira Lal Goel; Loredana Moro; Joanne E Murphy-Ullrich; Chung-Cheng Hsieh; Chin-Lee Wu; Zhong Jiang; Lucia R Languino
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.